Genesis Therapeutics rakes in $52m Series A

Genesis Therapeutics, a provider of AI technologies to create medicines for patients with severe and unmet medical needs, has raised $52 million in Series A financing.

Genesis Therapeutics, a provider of AI technologies to create medicines for patients with severe and unmet medical needs, has raised $52 million in Series A financing. Rock Springs Capital led the round.

Source: Press Release